Showing results (391-400 of 463) with videos related to

Sort By:
Pageof 47
European Journal of Internal Medicine|May 15, 2015
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and managementMatthieu Groh, Christian Pagnoux, Chiara Baldini, et al.
RMD Open|December 31, 2025
Concordance between presenting features and relapse in granulomatosis with polyangiitis: implications for risk assessment and counsellingMichele Iudici, Zubeyir Salis, Pascal Cohen, et al.
Annals of the Rheumatic Diseases|May 5, 2018
Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitidesBenjamin Terrier, Christian Pagnoux, Élodie Perrodeau, et al.
Nature Reviews. Rheumatology|September 15, 2017
Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitisXavier Bossuyt, Jan-Willem Cohen Tervaert, Yoshihiro Arimura, et al.
Arthritis and Rheumatism|October 10, 2012
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohortCloé Comarmond, Christian Pagnoux, Mehdi Khellaf, et al.
The New England Journal of Medicine|November 6, 2014
Rituximab versus azathioprine for maintenance in ANCA-associated vasculitisLoïc Guillevin, Christian Pagnoux, Alexandre Karras, et al.
Arthritis and Rheumatism|July 27, 2012
Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesisMaxime Samson, Sylvain Audia, Jennifer Fraszczak, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 19, 2015
Treatment of systemic necrotizing vasculitides in patients aged sixty-five years or older: results of a multicenter, open-label, randomized controlled trial of corticosteroid and cyclophosphamide-based induction therapyChristian Pagnoux, Thomas Quéméneur, Jacques Ninet, et al.
Journal of Autoimmunity|October 16, 2025
Evaluation of the mycophenolate mofetil-rituximab combination in systemic sclerosis: a French retrospective multicenter study (MycRiSSc)François Barde, Kevin Chevalier, Paul Decker, et al.
European Journal of Cancer (Oxford, England : 1990)|November 23, 2021
Anti-programmed death ligand 1 immunotherapies in cancer patients with pre-existing systemic sclerosis: A postmarketed phase IV safety assessment studyMarion Panhaleux, Olivier Espitia, Benjamin Terrier, et al.
Pageof 47